Market Tracker

09/02 2:52pm ET

Theravance Inc (NASDAQ:THRX)

23.06
Real-Time Quote
 -0.50 / -2.12%
Today’s Change
20.23
Today|||52-Week Range
34.52
-19.70%
Year-to-Date

Today’s Trading

Previous close23.56
Today’s open23.74
Day’s range22.84 - 23.84
Volume420,562
Average volume (3 months)1,119,679
Market cap$2.7B
Dividend yield4.33%
Data as of 2:36pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+40.12%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book8.78

Competitors

 Today’s
change
Today’s
% change
WXWuXi Pharmatech (Cay...+0.08+0.22%
MYGNMyriad Genetics Inc-0.59-1.63%
MNKDMannkind Corp-0.16-2.17%
ACADACADIA Pharmaceutica...+2.80+11.68%
Data as of 2:52pm ET, 09/02/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts